This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Kg. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Wilfried Goldschmidt: Innovator in Pharmaceutical Chemistry
Introduction
Wilfried Goldschmidt is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug development. His work has been recognized for its impact on the preparation of important chemical compounds.
Latest Patents
Goldschmidt holds a patent for a process titled "Process for preparing 1,3-dimethyl-4,5-diaminouracil." This invention relates to an improved method for synthesizing 1,3-dimethyl-4,5-diaminouracil by utilizing catalytic reduction of 1,3-dimethyl-4-amino-5-nitrosouracil in the presence of a palladium/charcoal catalyst. This advancement is crucial for enhancing the efficiency and effectiveness of pharmaceutical formulations.
Career Highlights
Throughout his career, Goldschmidt has been associated with Boehringer Ingelheim KG, a leading global pharmaceutical company. His role in the company has allowed him to contribute to various innovative projects and research initiatives aimed at improving healthcare solutions.
Collaborations
Goldschmidt has worked closely with his coworker, Rolf Dach, on various projects within the pharmaceutical sector. Their collaboration has fostered a productive environment for innovation and development in drug synthesis.
Conclusion
Wilfried Goldschmidt's contributions to pharmaceutical chemistry, particularly through his patented processes, highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in drug development and synthesis.